Howard Hughes Medical Institute’s Willis Towers Watson WTW Stock Holding History

Howard Hughes Medical Institute’s Portfolio WTW Stock Details WTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21	Closed	-$6.9K	–	484
2025 Q4	$6.9K	Hold	21	–	–	﹤0.01%	281
2025 Q3	$7.25K	Hold	21	–	–	﹤0.01%	269
2025 Q2	$6.44K	Buy	+21	New	+$6.51K	﹤0.01%	279

Other funds holding WTW

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Howard Hughes Medical Institute's WTW Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Willis Towers Watson (WTW) in Q1 2026, closing a stake of 21 shares — an estimated $6.9K sold.

Howard Hughes Medical Institute first reported a position in WTW in Q2 2025 and held it in 3 quarters. The position peaked at $7.25K in Q3 2025. 718 funds tracked by Wall St. Rank hold WTW as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Willis Towers Watson position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 21 Willis Towers Watson shares in Q1 2026, an estimated $6.9K.
Howard Hughes Medical Institute first reported a position in Willis Towers Watson in Q2 2025 and held it in 3 quarters.
Howard Hughes Medical Institute's Willis Towers Watson position peaked at $7.25K in Q3 2025.
718 funds tracked by Wall St. Rank held Willis Towers Watson as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.